Medpedia

Feb 02, 12 02:30PM | 0 comments

Researchers at Translational Genomics Research Institute (TGen) and Van Andel Research Institute (VARI) today presented study results in which they conclude that a combination drug therapy may be needed to combat non-small cell lung cancer (NSCLC).

Non-small cell lung carcinoma (NSCLC) is characterized by a remarkable variety of genomic alterations and point…

Comments

To add a comment to the original post, click here.

You must be signed in to post a comment.

Sign in now

There are no comments for this post.

Editor Directory - browse by last initial
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Professional Directory - browse by last initial
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Cancel